Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DexPK: Dexmedetomidine PK in Children
NCT03668951Phase 1Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Aug 2018
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dexmedetomidine in heart disease (3 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoints: Maximum blood concentration level of Dex and Time to maximum blood concentration. Started Aug 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
heart disease
Beyond the preview
Go deeper on NCT03668951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03668951.